GNRH1 and breast cancer: Then and for both stages of BC, adjuvant and non-adjuvant endocrine therapy and/or ovarian ablation (releasing hormone antagonists GnRH, LH-RH, and others) are used to prevent the growth, spread, and recurrence of hormone-responsive cells [9].